No Data
No Data
Preview: Os Therapies Incorporated Set To IPO Tomorrow
OS Therapies Incorporated (NYSE:OSTX) IPO will take place June, 21 on the NYSE exchange under the ticker OSTX.The company is offering shares at an expected price of $4.00 per share with an insider lo
Preview of the Week: Several officials from the Federal Reserve will appear with “terrifying data”! US stock market closed on Wednesday for a day.
China's June LPR is about to be released; the National Bureau of Statistics will publish multiple economic data; the initial jobless claims in the United States for the week will be announced soon.
OS Therapies Announces Positive Clinical Update From Ongoing Phase 2b Clinical Trial in Resected, Recurrent Osteosarcoma
OS Therapies, Inc. (NYSE-A: OSTX), a clinical-stage oncology-focused immunotherapy company developing cancer vaccines and antibody drug conjugate (ADC) therapeutic candidates, today announced a positive clinical update for AOST-2121 (NCT04974008), its ongoing Phase 2b clinical trial of its immunotherapy OST-HER2 (OST31-154) in patients with resected, recurrent osteosarcoma.
Oncology Drug Developer OS Therapies Refiles for $8M IPO
OS Therapies (OSTX) has refiled to raise $8M through a proposed initial public offering.
OS Therapies Incorporated | 10-Q: Quarterly report
No Data